Organoids from cervical precancer flag NF1 as the gatekeeper: losing it yields tumors in 42 days, and an AI-designed peptide cuts lesions in mice
High-grade squamous intraepithelial lesions of the cervix usually take years to possibly become invasive cancer, and the molecular gate restraining that transition was unclear. Combining patient-derived precancerous organoids, single-cell transcriptomics and CRISPR-Cas9 selection in vitro and in vivo, the study pins NF1 as the top suppressor of malignant transition in HPV-positive precancerous organoids: NF1-deficient organoids formed tumors within 42 days under the skin of immunodeficient mice, while control organoids failed to engraft. AlphaFold3-guided modeling then produced Pep-NF1, an NF1 GAP-mimetic peptide that lowered cervical lesion-associated bioluminescence in an HPV16-driven mouse model alongside local immune changes.